ALMITRINE - Watsons Health

ALMITRINE

Description: A respiratory stimulant that enhances breathing by increasing the oxygen int he blood while decreasing the carbon dioxide content in patients with chronic obstructive pulmonary disease. It may also prove useful in the treatment of nocturnal oxygen desaturation without impairing the quality of sleep. It has advantages over other drugs, as it is well tolerated, with minimal side effects.
Dosage: Adult : PO 50-100 mg/day in 2 divided doses.  IV Up to 3 mg/kg/day in 2 or 3 divided doses via IV infusion.
Dosage Details: Intravenous

Respiratory stimulant in acute respiratory failure

Adult: Up to 3 mg/kg/day, in 2 or3 divided doses via IV infusion with each dose being infused over 2 hr.

Oral

Respiratory stimulant in acute respiratory failure

Adult: 50-100 mg daily, given in 2 divided doses. Treatment  may be intermittent.

Adverse Drug Reactions: May cause weakness in lower extremities. Headache and gastrointestinal side effects
Brands:
  • Duxil
  • Vectarion
Therapeutic Category: Respiratory stimulants

Related Articles

DTP-HIB Vaccine

DTP-HIB vaccine is a combined vaccine of adsorbed diphtheria, tetanus toxoid and acellular pertussis and of Haemophilus influenzae type b conjugate vaccines. It is a [...]

Tenecteplase

Tenecteplase is a tissue-type plasminogen activator (tPA), a biosynthetic form of human enzyme that is a fibrin-specific thrombolytic agent, converting plasminogen to [...]

Selexipag

Selexipag is a selective non-prostanoid agonist of prostacyclin (IP) receptor, that stimulates the release of prostacyclin, which is responsible to induce [...]